Effective use of keishibukuryogan in subcutaneous hematoma after implantable cardiac device surgery in two cases

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Keishibukuryogan is a Kampo medicine that induces vasodilation and improves the blood flow velocity in subcutaneous blood vessels. We herein report two cases in which keishibukuryogan completely diminished subcutaneous hematoma after cardiac resynchronization therapy pacemaker implantation and defibrillator battery replacement within a month. Keishibukuryogan can be a good option for treating or preventing subcutaneous hematoma after surgical procedures for devices.

Cite

CITATION STYLE

APA

Kumanomido, J., Ohe, M., Shibata, R., Hattori, Y., Ishizaki, Y., Ito, S., … Fukumoto, Y. (2021). Effective use of keishibukuryogan in subcutaneous hematoma after implantable cardiac device surgery in two cases. Internal Medicine, 60(5), 755–759. https://doi.org/10.2169/internalmedicine.5677-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free